Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects
- PMID: 4620295
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects
Similar articles
-
Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.Tubercle. 1974 Mar;55(1):81-9. Tubercle. 1974. PMID: 4470836 No abstract available.
-
Side effects observed during intermittent rifampicin therapy.Scand J Respir Dis Suppl. 1973;84:129-31. Scand J Respir Dis Suppl. 1973. PMID: 4522066 No abstract available.
-
[Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects].Ann Parasitol Hum Comp. 1976 Jan-Feb;51(1):143-56. Ann Parasitol Hum Comp. 1976. PMID: 937975 French.
-
Isoniazid--the pivot of chemotherapy in tuberculosis.Indian Pediatr. 1990 Feb;27(2):119-23. Indian Pediatr. 1990. PMID: 2193884 Review. No abstract available.
-
"Allergic" reactions during rifampicin treatment: a review of published cases.Scand J Respir Dis Suppl. 1973;84:15-9. Scand J Respir Dis Suppl. 1973. PMID: 4593265 Review. No abstract available.
Cited by
-
Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis.Biomol Ther (Seoul). 2020 May 1;28(3):222-229. doi: 10.4062/biomolther.2020.001. Biomol Ther (Seoul). 2020. PMID: 32133828 Free PMC article. Review.
-
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.Clin Infect Dis. 2015 Aug 15;61(4):527-35. doi: 10.1093/cid/civ323. Epub 2015 Apr 22. Clin Infect Dis. 2015. PMID: 25904367 Free PMC article. Clinical Trial.
-
Rifampin-Associated Flu-Like Syndrome in a Patient Undergoing Treatment for a Device-Related Infection.Cureus. 2020 Dec 28;12(12):e12336. doi: 10.7759/cureus.12336. Cureus. 2020. PMID: 33520532 Free PMC article.
-
Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection.CMAJ. 2023 Sep 5;195(34):E1151-E1153. doi: 10.1503/cmaj.230317. CMAJ. 2023. PMID: 37669793 Free PMC article. No abstract available.
-
Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI.J Clin Med. 2019 Jun 6;8(6):812. doi: 10.3390/jcm8060812. J Clin Med. 2019. PMID: 31174321 Free PMC article.